Sisram Medical Ltd

1696

IL0011418113

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-05-14 am EDT			5-day change	1st Jan Change
4.26 ^HKD	-1.16%		+8.40%	-19.01%

Mar. 21	Sisram Medical’s Profit Down in Fiscal 2023	MT
Mar. 20	Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023	CI

Sisram Medical Ltd Appoints Heung Sang Addy Fong and Chi Fung Leo Chan as an External Director

December 22, 2017 at 06:34 am EST

Sisram Medical Ltd. at its Extraordinary General Meeting held on 22 December 2017 approved the appointment of Mr. Heung Sang Addy Fong and Chi Fung Leo Chan as an external director of the company.

Latest news about Sisram Medical Ltd

Sisram Medical’s Profit Down in Fiscal 2023	Mar. 21	MT
Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023	Mar. 20	CI
Sisram Medical Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Sisram Medical Ltd Enters into Strategic Partnership with Prollenium	Jan. 08	CI
Sisram Medical Ltd Announces the Registration Application of Profhilo	Nov. 29	CI
Sisram Medical Expects 2023 Revenue To Be Consistent Amid Israel War; Shares Drop 5%	Nov. 13	MT
Sisram Medical's H1 Profit on Lower Revenue	23-08-24	MT
Sisram Medical Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Sisram Medical Ltd Announces Final Ordinary Dividend for the Year Ended December 31, 2022, Payable 07 September 2023	23-08-11	CI
Sisram Medical Announces the Launch of Alma Veil for the U.S. Market	23-07-25	CI
Sisram Medical Completes Acquisition of Business Related to Alma Lasers	23-06-29	MT
PhotonMed HK completed the acquisition of 40% stake in Alma Hong Kong 2023 Limited from Sisram Medical Ltd.	23-06-27	CI
FDA Clears Sisram Medical's Adipose Tissue Processing Device for Marketing in the US	23-06-16	MT
Sisram Medical Ltd. Receives the Clearance from the U.S. Food and Drug Administration	23-06-16	CI
Chinese Regulator Accepts Sisram Medical’s Drug Registration Application	23-04-11	MT
Sisram Medical Ltd Announces Drug Registration Application of Rt002	23-04-11	CI
PhotonMed HK entered into an agreement to acquire 40% stake in Alma Hong Kong 2023 Limited from Sisram Medical Ltd for CNY 270 million.	23-03-29	CI
Sisram Medical Ltd Provides Revenue Guidance for the Year 2023	23-03-21	CI
Sisram Medical Ltd Declares a Final Dividend for the Year Ended December 31, 2022	23-03-21	CI
Sisram Medical Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Executive Director of the Company with Effect from January 1, 2023	22-12-29	CI
Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Chief Financial Officer of the Company with Effect from January 1, 2023	22-12-29	CI
Sisram Medical's H1 Net Profit Rises 25.9%	22-08-21	MT
Sisram Medical Ltd Provides Revenue Guidance for the Year 2022	22-08-19	CI
Sisram Medical Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI

Sisram Medical Ltd is an investment holding company principally engaged in the design, development, manufacture and distribution of energy cosmetic medicine and minimally invasive medical cosmetic treatment systems. The Company has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The Company's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The company sells its products in domestic and foreign markets.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-20 - Q2 2024 Earnings Release (Projected)

More about the company